04
The Marinomed (biotechnology) case study shows how strong IP protection is a prerequisite in the biopharmaceutical market due to easy imitation to (1) recover high R&D investments &; (2) overcome a long and expensive approval stage.
The Marinomed (biotechnology) case study shows how strong IP protection is a prerequisite in the biopharmaceutical market due to easy imitation to (1) recover high R&D investments &; (2) overcome a long and expensive approval stage.